Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis

[1]  D. Celermajer,et al.  Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment , 2007, Internal medicine journal.

[2]  David Abraham,et al.  Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.

[3]  I. Chikanza,et al.  Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis , 2006, Nature Clinical Practice Rheumatology.

[4]  K. Kostikas,et al.  Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe? , 2006, Respiratory research.

[5]  D. Furst,et al.  Systemic and localized scleroderma. , 2006, Clinics in dermatology.

[6]  R. Tkacova,et al.  Systemic inflammation in patients with COPD and pulmonary hypertension. , 2006, Chest.

[7]  P. Sterk,et al.  Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[8]  D. Mccrory,et al.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[9]  A. Torbicki,et al.  Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[10]  N. Hill,et al.  Evaluation and management of pulmonary hypertension in systemic sclerosis , 2003, Current opinion in rheumatology.

[11]  S. Black,et al.  Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[12]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[13]  K. Hirata,et al.  Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  M. Fujita,et al.  Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression. , 2002, Journal of applied physiology.

[15]  M. Conforti,et al.  Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers , 2002, Arthritis research.

[16]  N. Voelkel,et al.  Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension , 2002, Critical care medicine.

[17]  D. Stewart,et al.  Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension , 2001, Circulation.

[18]  G. Semenza,et al.  Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.

[19]  A. Reali,et al.  Left ventricular diastolic function in systemic sclerosis. , 2001, The Journal of rheumatology.

[20]  Y. Dor,et al.  Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. , 2001, American journal of physiology. Cell physiology.

[21]  P. Hirth,et al.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  M. Humbert,et al.  Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. , 2000, American journal of respiratory and critical care medicine.

[23]  Y. Hosoda,et al.  Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension , 2000, Pathology international.

[24]  K. Meyer,et al.  Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. , 2000, The Journal of laboratory and clinical medicine.

[25]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  S. Eddahibi,et al.  Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. , 1998, The American journal of physiology.

[27]  Yazawa,et al.  Serum concentrations of vascular endothelial growth factor in collagen diseases , 1998, The British journal of dermatology.

[28]  N. Voelkel,et al.  Pulmonary hypertension and inflammation. , 1998, The Journal of laboratory and clinical medicine.

[29]  S. Kourembanas,et al.  Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. , 1998, American journal of respiratory cell and molecular biology.

[30]  M. Tischler,et al.  Prevalence of pulmonary hypertension in limited and diffuse scleroderma. , 1996, Chest.

[31]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[32]  M. Petri,et al.  Pulmonary hypertension in systemic lupus erythematosus. , 1989, The Journal of rheumatology.

[33]  N. Dean,et al.  Noninvasive Evaluation of Pulmonary Artery Pressure During Exercise by Saline-Enhanced Doppler Echocardiography in Chronic Pulmonary Disease , 1989, Circulation.

[34]  C K Wells,et al.  Evaluation of clinical methods for rating dyspnea. , 1988, Chest.

[35]  J. Seward,et al.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. , 1985, Journal of the American College of Cardiology.

[36]  P. Yock,et al.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. , 1984, Circulation.

[37]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[38]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[39]  Yue-ying Gu,et al.  Pulmonary hypertension in systemic lupus erythematosus , 1999, Rheumatology International.

[40]  A. Buist.  Standardization of spirometry. , 1987, The American review of respiratory disease.